<VariationArchive VariationID="960380" VariationName="NM_000891.3(KCNJ2):c.721del (p.Glu241fs)" VariationType="Deletion" Accession="VCV000960380" Version="7" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-03-05" DateCreated="2020-07-16" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="950259" VariationID="960380">
      <GeneList>
        <Gene Symbol="KCNJ2" FullName="potassium inwardly rectifying channel subfamily J member 2" GeneID="3759" HGNC_ID="HGNC:6263" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="70169532" stop="70180044" display_start="70169532" display_stop="70180044" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="68165675" stop="68176184" display_start="68165675" display_stop="68176184" Strand="+" />
          </Location>
          <OMIM>600681</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000891.3(KCNJ2):c.721del (p.Glu241fs)</Name>
      <CanonicalSPDI>NC_000017.11:70175756:GGGG:GGG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17q24.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="70175757" stop="70175757" display_start="70175757" display_stop="70175757" variantLength="1" positionVCF="70175756" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="68171898" stop="68171898" display_start="68171898" display_stop="68171898" variantLength="1" positionVCF="68171897" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>E241fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_328" sequenceAccession="LRG_328">
            <Expression>LRG_328:g.11226del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_328t1" sequenceAccession="LRG_328t1">
            <Expression>LRG_328t1:c.721del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.68171901del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.68171901del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.70175760del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.70175760del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008798.1" sequenceAccession="NG_008798" sequenceVersion="1" change="g.11226del">
            <Expression>NG_008798.1:g.11226del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000891.3" sequenceAccession="NM_000891" sequenceVersion="3" change="c.721del" MANESelect="true">
            <Expression>NM_000891.3:c.721del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000882.1" sequenceAccession="NP_000882" sequenceVersion="1" change="p.Glu241fs">
            <Expression>NP_000882.1:p.Glu241fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2074388917" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000891.3(KCNJ2):c.721del (p.Glu241fs) AND multiple conditions" Accession="RCV001233893" Version="7">
        <ClassifiedConditionList TraitSetID="9142">
          <ClassifiedCondition DB="MedGen" ID="C1563715">Andersen Tawil syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1865018">Short QT syndrome type 3</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-09-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-09-08" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-07-16" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="9142" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="244" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Andersen Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Andersen cardiodysrhythmic periodic paralysis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Long QT syndrome 7</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Periodic paralysis, potassium-sensitive cardiodysrhythmic type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Andersen Tawil syndrome</ElementValue>
                <XRef ID="Andersen+Tawil+Syndrome/431" DB="Genetic Alliance" />
                <XRef ID="422348008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">ATS</ElementValue>
                <XRef Type="MIM" ID="170390" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">LQT7</ElementValue>
                <XRef Type="MIM" ID="170390" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9453" />
                <XRef ID="9453" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Andersen-Tawil syndrome (ATS) is characterized by a triad of: episodic flaccid muscle weakness (i.e., periodic paralysis); ventricular arrhythmias and prolonged QT interval; and anomalies including low-set ears, widely spaced eyes, small mandible, fifth-digit clinodactyly, syndactyly, short stature, and scoliosis. Affected individuals present in the first or second decade with either cardiac symptoms (palpitations and/or syncope) or weakness that occurs spontaneously following prolonged rest or following rest after exertion. Mild permanent weakness is common. Mild learning difficulties and a distinct neurocognitive phenotype (i.e., deficits in executive function and abstract reasoning) have been described.</Attribute>
                <XRef ID="NBK1264" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301308</ID>
                <ID Source="BookShelf">NBK1129</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301441</ID>
                <ID Source="BookShelf">NBK1264</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2010">
                <ID Source="PubMed">20298421</ID>
              </Citation>
              <XRef ID="37553" DB="Orphanet" />
              <XRef ID="C1563715" DB="MedGen" />
              <XRef ID="MONDO:0008222" DB="MONDO" />
              <XRef Type="MIM" ID="170390" DB="OMIM" />
            </Trait>
            <Trait ID="3722" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Short QT syndrome type 3</ElementValue>
                <XRef ID="MONDO:0012314" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">SQT3</ElementValue>
                <XRef Type="MIM" ID="609622" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18635" />
                <XRef ID="18635" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="HRS/EHRA, 2012">
                <ID Source="PubMed">21810866</ID>
              </Citation>
              <XRef ID="51083" DB="Orphanet" />
              <XRef ID="C1865018" DB="MedGen" />
              <XRef ID="MONDO:0012314" DB="MONDO" />
              <XRef Type="MIM" ID="609622" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2741534" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2020-07-16">
        <ClinVarSubmissionID localKey="7640867|MedGen:C1865018;C1563715" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001406508" DateUpdated="2024-02-28" DateCreated="2020-07-16" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-09-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant disrupts the C-terminus of the KCNJ2 protein. Other variant(s) that disrupt this region (p.Leu368Serfs*39) have been determined to be pathogenic (Invitae). This suggests that variants that disrupt this region of the protein are likely to be causative of disease. This variant has not been reported in the literature in individuals with KCNJ2-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change results in a premature translational stop signal in the KCNJ2 gene (p.Glu241Serfs*8). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 187 amino acids of the KCNJ2 protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNJ2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.68171898del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1865018" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1563715" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2741534" TraitType="Disease" MappingType="XRef" MappingValue="C1865018" MappingRef="MedGen">
        <MedGen CUI="C1865018" Name="Short QT syndrome type 3" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2741534" TraitType="Disease" MappingType="XRef" MappingValue="C1563715" MappingRef="MedGen">
        <MedGen CUI="C1563715" Name="Andersen Tawil syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

